STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway
STAT [Unofficial]
April 16, 2026
How a rare disease drugmaker won FDA approval after a clinical trial disappointed.
Discussion in the ATmosphere